LeMaitre Vascular, Inc. (NASDAQ:LMAT) Files An 8-K Results of Operations and Financial Condition
Item2.02. Results of Operations and Financial Condition.
On April26, LeMaitre Vascular, Inc. (the Company) issued a press
release regarding its financial and operational results for the
quarter ended March31, 2017. A copy of the press release is
furnished as Exhibit 99.1 to this Report.
The information in this Item 2.02, including Exhibit 99.1
attached hereto, is intended to be furnished and shall not be
deemed filed for purposes of Section18 of the Securities Exchange
Act of 1934 (the Exchange Act) or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or
the Exchange Act, except as expressly set forth by specific
reference in such filing.
Item9.01. Financial Statements and Exhibits.
The following exhibits are furnished or filed as part of this
Report, as applicable:
(d) Exhibits.
|
Exhibit No. |
Description |
|
| 99.1 |
Press release issued by LeMaitre Vascular, Inc. on April26, 2017. |
(s)
About LeMaitre Vascular, Inc. (NASDAQ:LMAT)
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company’s product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch. LeMaitre Vascular, Inc. (NASDAQ:LMAT) Recent Trading Information
LeMaitre Vascular, Inc. (NASDAQ:LMAT) closed its last trading session up +0.75 at 26.38 with 127,183 shares trading hands.